An executive at JPMorgan recently stated that the backlash against issues related to environmental, social and governance (ESG) in the United …
Maven Clinic’s $125 million Series F funding round was led by StepStone Group and included participation from existing investors General …
John Thurston, Arkansas secretary of state, has rejected a proposed amendment aimed at broadening access to medical cannabis. …
Canada Nickel (TSX.V: CNC) (OTC: CNIKF), a company that is advancing the next generation of nickel-sulphide projects, has been conditionally …
HLTH, scheduled for October 20-23 in Las Vegas, spotlights individuals across the healthcare ecosystem from high-powered executives such as the …
Flora Growth (NASDAQ: FLGC), a consumer-packaged goods leader and pharmaceutical distributor, has released a statement regarding the German …
On the heels of Phase 3 data showing muscle improvement in the rare neuromuscular disease spinal muscular atrophy, Scholar Rock raised $300 …
SOBR Safe (NASDAQ: SOBR) (“SOBRsafe”), a provider of next-generation transdermal alcohol detection solutions, today announced the closure of …
Shares of Trump Media & Technology Group (NASDAQ: DJT), the operator of Truth Social, have recently experienced a notable surge, climbing up to …
Oragenics (NYSE American: OGEN), a biopharmaceutical company committed to developing novel therapies for neurological disorders, has released a …
Laredo Oil (OTC: LRDC), an exploration and production company, today announced that it has sold 1,695,349 shares of common stock to accredited …
If you thought that Big Pharma and the PBMs were the only bad guys in the saga of unreasonably high prescription drug prices in the United …
Longeveron (NASDAQ: LGVN), a clinical-stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and …
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, announced Wednesday morning that dosing has begun for …